The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 952 participants.
Also called NCT02030418
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 952 participants
- Sponsor
- Registry
-
NCT02030418
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Canada
- Registry status
- Completed
Technical summary
Registry record NCT02030418. Allocation not applicable; no masking; primary purpose treatment. Start 2014-02 (actual); primary completion 2015-06 (actual). Results posted on 2025-07-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker
- Condition
- Bradycardia
- Intervention (Device)
- Leadless Pacemaker
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct02030418- Content hash
d6a82ed308da520012d01f9d50d2f9ecb78d3f64d3103ac25b39d5147da1ad09